Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|August 29, 2000
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternativeF Cappuzzo, C M Rocha Lima, C A Sherman, et al.Forum (Genoa, Italy)|July 6, 2000
Medical treatment of brain metastases from solid tumoursF Cappuzzo, F Mazzoni, A Maestri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trialG L Ceresoli, F Cappuzzo, V Gregorc, et al.Journal of Cancer Research and Clinical Oncology|July 7, 2012
First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II studyC Tibaldi, A Camerini, A D'Incecco, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidenceC Gridelli, F De Marinis, M Di Maio, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issuesC Gridelli, F De Marinis, M Di Maio, et al.Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1997
Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized studyF Bozzetti, L Biganzoli, C Gavazzi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyB Coudert, T Ciuleanu, K Park, et al.Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.Journal of Endocrinological Investigation|March 23, 2024
Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumorsA La Salvia, B Marcozzi, C Manai, et al.Pageof 6